Psilocybin prevents activity-based anorexia in female rats by enhancing cognitive flexibility: contributions from 5-HT1A and 5-HT2A receptor mechanisms
bioRxiv (Cold Spring Harbor Laboratory) December 13, 2023 Kyna‐anne Conn, Lk Milton, Kaixin Huang et al. 6 citations preprint
Abstract Psilocybin has shown promise for alleviating symptoms of depression and is currently in clinical trials for the treatment of anorexia nervosa (AN), a condition that is characterised by persistent cognitive inflexibility. Considering that enhanced cognitive flexibility after psilocybin treatment is reported to occur in individuals with depression, it is plausible that psilocybin could...
DOI: 10.1101/2023.12.12.571374 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Cognitive flexibility
Cognition
Flexibility engineering
+5